사르탄(Sartans) 시장 보고서(2026년)

Sartans, also known as angiotensin II receptor blockers (ARBs), are medications commonly used to treat high blood pressure (hypertension) and heart failure. They work by blocking the effects of angiotensin II, a hormone that constricts blood vessels, thereby promoting vessel relaxation, lowering blood pressure, and improving circulation. Sartans also help reduce the risk of strokes, kidney damage, and heart attacks in patients with certain cardiovascular conditions.

The main types of sartans include valsartan, telmisartan, losartan, irbesartan, azilsartan, and olmesartan. Valsartan is an angiotensin II receptor blocker that lowers blood pressure and decreases cardiac strain by relaxing blood vessels. These medications are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels, and are used for applications such as hypertension, cardiovascular diseases, kidney diseases, and more. End users include hospitals, diagnostic laboratories, and other healthcare facilities.

Tariffs have impacted the sartans market by increasing the cost of imported APIs and pharmaceutical intermediates used in antihypertensive drug manufacturing. These impacts are most pronounced in generic drug manufacturing hubs across Asia Pacific and Europe, where large scale production relies on cross border sourcing. Rising tariff related expenses have pressured pricing structures and procurement margins for manufacturers and distributors. This has influenced sourcing strategies and competitive dynamics in both domestic and export markets. However, tariffs have encouraged domestic API production, localized sourcing initiatives, and strengthened long term supply chain resilience.

The sartans market research report is one of a series of new reports from The Business Research Company that provides sartans market statistics, including sartans industry global market size, regional shares, competitors with a sartans market share, detailed sartans market segments, market trends and opportunities, and any further data you may need to thrive in the sartans industry. This sartans market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sartans market size has grown steadily in recent years. It will grow from $22.18 billion in 2025 to $23.09 billion in 2026 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to high global hypertension prevalence, cardiovascular disease burden, generic drug adoption, hospital-based prescribing, long-term safety profile of sartans.

The sartans market size is expected to see steady growth in the next few years. It will grow to $27.14 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to aging population, rising kidney disease incidence, demand for cost-effective therapies, outpatient treatment expansion, growth of digital pharmacies. Major trends in the forecast period include increasing use in hypertension management, growth of generic angiotensin receptor blockers, preference for combination cardiovascular therapy, expansion of online pharmacy distribution, focus on renal and cardiovascular protection.

The rising prevalence of hypertension is expected to drive the growth of the sartans market in the coming years. Hypertension is a condition characterized by persistently high blood pressure, increasing the risk of heart disease, stroke, and other serious health complications. Its growing incidence is largely associated with diets high in salt and processed foods, which cause fluid retention and place additional strain on the heart. Sartans manage hypertension by blocking angiotensin II, a hormone that constricts blood vessels. This action relaxes and widens the vessels, lowers blood pressure, and reduces the heart's workload. For example, in September 2025, the World Health Organization, a Switzerland-based international public health agency, reported that approximately 1.4 billion adults aged 30-79 worldwide were living with hypertension in 2024, representing about 33% of the global population. Therefore, the rising prevalence of hypertension is boosting the sartans market.

Major companies operating in the sartans market are focusing on developing advanced products, such as tablet-form sartans, to improve treatment effectiveness and patient adherence. Tablet-form sartans are oral medications that block the effects of angiotensin II, promoting vessel relaxation and reducing blood pressure. For instance, in July 2024, Zydus Lifesciences, an India-based pharmaceutical company, received US FDA approval for Valsartan Tablets USP (40 mg, 80 mg), marketed under the brand name Diovan. These tablets are prescribed for hypertension, heart failure, and to improve survival after heart attack in adults, and are also approved for pediatric patients aged one year and older.

In April 2025, Scienture Holdings, Inc., a US-based sartan manufacturer, partnered with Saptalis Pharmaceuticals to produce Arbli (losartan potassium oral suspension, 10 mg/mL). The collaboration includes warehousing and distribution agreements with strategic partners to ensure market readiness for the first FDA-approved ready-to-use oral liquid losartan, addressing unmet needs in hypertension treatment. Saptalis Pharmaceuticals is a US-based pharmaceutical company.

Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Abbott Laboratories, Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co. Inc.

North America was the largest region in the sartans market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sartans market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sartans market consists of sales of candesartan, eprosartan, and fimasartan. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sartans Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses sartans market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sartans ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sartans market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Valsartan; Telmisartan; Losartan; Irbesartan; Azilsartan; Olmesartan
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 3) By Application: Hypertension; Cardiovascular Diseases; Kidney Diseases; Other Applications
• 4) By End-User: Hospitals; Other End-Users
• Subsegments:
• 1) By Valsartan: Film-Coated Tablets; Oral Powder Sachets; Triple-Combination Tablets; Ready-To-Use Liquid Formulations
• 2) By Telmisartan: Soft Gel Capsules; Mouth-Dissolving Strips; Sustained-Release Tablets; Sachet-Packed Granules
• 3) By Losartan: Chewable Tablets; Pediatric Oral Drops; Effervescent Tablets; Dispersible Tablets
• 4) By Irbesartan: High-Potency Tablets; Scored Tablets; Hospital Bulk Packs; Blister Strip Packs
• 5) By Azilsartan: Nanoparticle-Based Tablets; Rapid-Onset Tablets; Unit-Dose Capsules; Microgranule Sachets
• 6) By Olmesartan: Oral Jelly Formulations; Oral Thin Films; Powder-For-Suspension Packs; Dual-Layer Tablets
• Companies Mentioned: Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Intas Pharmaceuticals Ltd.; Sun Pharmaceutical Industries Ltd.; Apotex Inc.; Aurobindo Pharma Ltd.; Dr. Reddy's Laboratories Ltd.; Cipla Ltd.; Cadila Pharmaceuticals Ltd.; Lupin Ltd.; Zydus Lifesciences Ltd.; Torrent Pharmaceuticals Ltd.; Alembic Pharmaceuticals Ltd.; Unichem Laboratories Ltd.; Emcure Pharmaceuticals Ltd.; Mylan N.V.; Hikma Pharmaceuticals PLC; Glenmark Pharmaceuticals Ltd.; Abbott Laboratories; Novartis AG; Pfizer Inc.; Sanofi S.A.; Takeda Pharmaceutical Company Limited; Bayer AG; Merck & Co. Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Sartans Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Sartans Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Sartans Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Sartans Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Fintech, Blockchain, Regtech & Digital Finance
• 4.2. Major Trends
  • 4.2.1 Increasing Use In Hypertension Management
  • 4.2.2 Growth Of Generic Angiotensin Receptor Blockers
  • 4.2.3 Preference For Combination Cardiovascular Therapy
  • 4.2.4 Expansion Of Online Pharmacy Distribution
  • 4.2.5 Focus On Renal And Cardiovascular Protection

5. Sartans Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Cardiology Centers
• 5.4 Retail Pharmacies
• 5.5 Online Pharmacies

6. Sartans Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sartans Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Sartans PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Sartans Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Sartans Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Sartans Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sartans Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sartans Market Segmentation

• 9.1. Global Sartans Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
• 9.2. Global Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
• 9.3. Global Sartans Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
• 9.4. Global Sartans Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Other End-Users
• 9.5. Global Sartans Market, Sub-Segmentation Of Valsartan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Film-Coated Tablets, Oral Powder Sachets, Triple-Combination Tablets, Ready-To-Use Liquid Formulations
• 9.6. Global Sartans Market, Sub-Segmentation Of Telmisartan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Soft Gel Capsules, Mouth-Dissolving Strips, Sustained-Release Tablets, Sachet-Packed Granules
• 9.7. Global Sartans Market, Sub-Segmentation Of Losartan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chewable Tablets, Pediatric Oral Drops, Effervescent Tablets, Dispersible Tablets
• 9.8. Global Sartans Market, Sub-Segmentation Of Irbesartan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• High-Potency Tablets, Scored Tablets, Hospital Bulk Packs, Blister Strip Packs
• 9.9. Global Sartans Market, Sub-Segmentation Of Azilsartan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nanoparticle-Based Tablets, Rapid-Onset Tablets, Unit-Dose Capsules, Microgranule Sachets
• 9.10. Global Sartans Market, Sub-Segmentation Of Olmesartan, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Jelly Formulations, Oral Thin Films, Powder-For-Suspension Packs, Dual-Layer Tablets

10. Sartans Market Regional And Country Analysis

• 10.1. Global Sartans Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Sartans Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sartans Market

• 11.1. Asia-Pacific Sartans Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sartans Market

• 12.1. China Sartans Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sartans Market

• 13.1. India Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sartans Market

• 14.1. Japan Sartans Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sartans Market

• 15.1. Australia Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Sartans Market

• 16.1. Indonesia Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Sartans Market

• 17.1. South Korea Sartans Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Sartans Market

• 18.1. Taiwan Sartans Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Sartans Market

• 19.1. South East Asia Sartans Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Sartans Market

• 20.1. Western Europe Sartans Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Sartans Market

• 21.1. UK Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Sartans Market

• 22.1. Germany Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Sartans Market

• 23.1. France Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Sartans Market

• 24.1. Italy Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Sartans Market

• 25.1. Spain Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Sartans Market

• 26.1. Eastern Europe Sartans Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Sartans Market

• 27.1. Russia Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Sartans Market

• 28.1. North America Sartans Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Sartans Market

• 29.1. USA Sartans Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Sartans Market

• 30.1. Canada Sartans Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Sartans Market

• 31.1. South America Sartans Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Sartans Market

• 32.1. Brazil Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Sartans Market

• 33.1. Middle East Sartans Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Sartans Market

• 34.1. Africa Sartans Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Sartans Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Sartans Market Regulatory and Investment Landscape

36. Sartans Market Competitive Landscape And Company Profiles

• 36.1. Sartans Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Sartans Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Sartans Market Company Profiles
  • 36.3.1. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Sartans Market Other Major And Innovative Companies

• Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Abbott Laboratories, Novartis AG

38. Global Sartans Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Sartans Market

40. Sartans Market High Potential Countries, Segments and Strategies

• 40.1 Sartans Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Sartans Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Sartans Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer